Highly selective κ-opioid receptor antagonist.
Product Specification
| Alternative Name: | nor-BNI . 2HCl |
| |
| Formula: | C40H43N3O6 . 2HCl |
| |
| MW: | 661.8 . 73.0 |
| |
| Purity: | ≥96% |
| |
| Appearance: | Tan solid. |
| |
| CAS: | 105618-26-6 |
| |
| Solubility: | Soluble in ethanol; sonification required. |
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Aqueous solutions are highly unstable and should be freshly prepared. |
| |
Please mouse over
Product Literature References
Differential agonist regulation of the human kappa-opioid receptor: A.D. Blake, et al.; J. Neurochem.
68, 1846 (1997),
Abstract;
Structure-activity relationship of N17'-substituted norbinaltorphimine congeners. Role of the N17' basic group in the interaction with a putative address subsite on the kappa opioid receptor: P.S. Portoghese, et al.; J. Med. Chem.
37, 1495 (1994),
Abstract;
Effects of the selective kappa opioid antagonist, nor-binaltorphimine, on electrically-elicited feeding in the rat: K.D. Carr, et al.; Life Sci.
45, 1787 (1989),
Abstract;
Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays: A.E. Takemori, et al.; J. Pharmacol. Exp. Ther.
246, 255 (1988),
Abstract;
Binaltorphimine and nor-binaltorphimine, potent and selective kappa- opioid receptor antagonists: P.S. Portoghese, et al.; Life Sci.
40, 1287 (1987),
Abstract;